comparemela.com
Home
Live Updates
Namodenoson Treatment for Pancreatic and Liver Cancer: Data will be Discussed in Out-licensing and Distribution Partnering Meetings at Bio Europe Conference -March 11, 2024 at 07:06 am EDT : comparemela.com
Namodenoson Treatment for Pancreatic and Liver Cancer: Data will be Discussed in Out-licensing and Distribution Partnering Meetings at Bio Europe Conference -March 11, 2024 at 07:06 am EDT
Can-Fite BioPharma Ltd. , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncology and inflammatory diseases, today announced its VP of Business...
Related Keywords
Spain ,
Ukraine ,
South Korea ,
Switzerland ,
Barcelona ,
Comunidad Autonoma De Cataluna ,
United States ,
China ,
Israel ,
Russia ,
Canada ,
Austria ,
Russian ,
Swiss ,
American ,
Gebro Pharma ,
Sari Fishman ,
Drug Administration ,
Vp Business Development At Can ,
Business Development ,
Fite Biopharma Ltd ,
Can Fite Biopharma ,
Europe Spring ,
Bio Europe Conference ,
Fite Biopharma ,
Orphan Drug Designation ,
Fast Track Designation ,
Annual Report ,
comparemela.com © 2020. All Rights Reserved.